Dr. Chan is an accomplished entrepreneur and biotechnology executive. He is a cofounder and CSO of NovoMedix, LLC and has over 30 years of experience in drug discovery and development to running clinical trials as well as building and financing start-up companies through private, public and non-dilutive capital markets. He was also the cofounder and Chief Technology Officer of BioTheryX, Inc., a clinical-stage targeted protein degrader company. Dr. Chan was formerly the head of Discovery Research at Celgene where he built and led technology programs in genomics, proteomics, and informatics as well as successfully managed therapeutic programs in virology, estrogen physiology, and the development of small molecule modulators of epigenetic programming and adult stem cells for regenerative medicine. He has served on scientific and business advisory boards for a number of biotech companies. Dr. Chan has authored numerous publications and holds over 30 U.S. patents.
